First Foundation Advisors Purchases 337 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

by · The Cerbat Gem

First Foundation Advisors increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 9,162 shares of the medical equipment provider’s stock after buying an additional 337 shares during the period. First Foundation Advisors’ holdings in Intuitive Surgical were worth $3,133,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. RB Capital Management LLC lifted its stake in Intuitive Surgical by 4.4% in the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after purchasing an additional 73 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Intuitive Surgical by 0.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock valued at $285,603,000 after buying an additional 5,233 shares in the last quarter. Baird Financial Group Inc. raised its position in shares of Intuitive Surgical by 2.3% during the 1st quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock valued at $6,362,000 after buying an additional 481 shares in the last quarter. Brown Brothers Harriman & Co. raised its position in shares of Intuitive Surgical by 576.7% during the 1st quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 346 shares in the last quarter. Finally, Covestor Ltd raised its position in shares of Intuitive Surgical by 50.4% during the 1st quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock valued at $126,000 after buying an additional 140 shares in the last quarter. Institutional investors own 82.91% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $309.52 on Wednesday. The firm’s 50 day moving average price is $288.35 and its 200-day moving average price is $305.71. Intuitive Surgical, Inc. has a 52-week low of $222.65 and a 52-week high of $358.07. The company has a market cap of $108.97 billion, a PE ratio of 72.83, a P/E/G ratio of 5.21 and a beta of 1.34.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.06. Intuitive Surgical had a net margin of 22.14% and a return on equity of 12.91%. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the firm earned $0.90 earnings per share. The company’s quarterly revenue was up 12.0% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.54 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now directly owns 702 shares in the company, valued at $214,587.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now directly owns 702 shares in the company, valued at $214,587.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 27,385 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $260.11, for a total transaction of $7,123,112.35. Following the completion of the sale, the chief executive officer now owns 23,551 shares of the company’s stock, valued at $6,125,850.61. The disclosure for this sale can be found here. Insiders sold a total of 55,208 shares of company stock worth $15,275,529 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on ISRG shares. HSBC started coverage on shares of Intuitive Surgical in a research report on Friday, November 17th. They set a “buy” rating and a $318.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and set a $355.00 target price on shares of Intuitive Surgical in a research report on Friday, October 20th. Morgan Stanley upped their target price on shares of Intuitive Surgical from $300.00 to $330.00 and gave the company an “equal weight” rating in a research report on Monday. SVB Leerink initiated coverage on shares of Intuitive Surgical in a research report on Monday, October 16th. They set an “outperform” rating and a $342.00 target price on the stock. Finally, Wells Fargo & Company reduced their price objective on shares of Intuitive Surgical from $386.00 to $363.00 and set an “overweight” rating on the stock in a research report on Friday, October 20th. Four research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $344.14.

Check Out Our Latest Research Report on ISRG

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).